166
Views
3
CrossRef citations to date
0
Altmetric
Research Article

Clinical experience with intravenous valproate as first-line treatment of status epilepticus and seizure clusters in selected populations

, , , , , , , , , & show all
Pages 30-36 | Received 04 Mar 2013, Accepted 15 Jun 2013, Published online: 19 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Alessandra Morano, Luigi Iannone, Caterina Palleria, Martina Fanella, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opinion on Pharmacotherapy 20:1, pages 25-39.
Read now

Articles from other publishers (2)

Igor Olegovich Gaydukov, Tatyana Aleksandrovna Voronina, Svetlana Aleksanrovna Litvinova & Inga Sergeevna Kutepova. (2020) Anticonvulsant activity of new 3- and 4-benzoilpiridines oxime derivatives in comparison with valproic acid. Medicinal Chemistry Research 29:4, pages 783-792.
Crossref
Fabio Minicucci, Monica Ferlisi, Francesco Brigo, Oriano Mecarelli, Stefano Meletti, Umberto Aguglia, Roberto Michelucci, Massimo Mastrangelo, Nicola Specchio, Stefano Sartori & Paolo Tinuper. (2020) Management of status epilepticus in adults. Position paper of the Italian League against Epilepsy. Epilepsy & Behavior 102, pages 106675.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.